E. Ohman J or Asset Management AB Purchases 700 Shares of Humana Inc. (NYSE:HUM)

E. Ohman J or Asset Management AB grew its position in shares of Humana Inc. (NYSE:HUM) by 14.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,488 shares of the insurance provider’s stock after buying an additional 700 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Humana were worth $1,392,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Atlas Brown Inc. grew its stake in shares of Humana by 0.6% during the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Moors & Cabot Inc. grew its stake in shares of Humana by 2.5% during the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the last quarter. Mather Group LLC. grew its stake in shares of Humana by 21.0% during the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the last quarter. OLD National Bancorp IN grew its stake in shares of Humana by 1.8% during the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock valued at $828,000 after purchasing an additional 45 shares during the last quarter. Finally, Your Advocates Ltd. LLP boosted its stake in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.29% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HUM. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Barclays raised their price objective on shares of Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a research note on Wednesday, January 22nd. KeyCorp began coverage on shares of Humana in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Stephens reaffirmed an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Finally, TD Cowen raised their price objective on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $297.68.

Humana Trading Down 1.7 %

Shares of NYSE:HUM opened at $290.52 on Thursday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company’s fifty day simple moving average is $275.13 and its 200 day simple moving average is $299.72. The firm has a market cap of $34.98 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 2.21 and a beta of 0.56.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.